- ALDX +53% on its lead product candidate successful in mid-stage dry eye study.
- AEMD +47% as FDA designates Aethlon' Hemopurifier for accelerated review.
- CTIC +7% on positive analyst action.
- TA +7% on the announcement that it has won its litigation against Comdata.
- TEVA +6% on selling Paragard asset to CooperSurgical for $1.1B.
- DRYS +5% on commencement of Its second very large gas carrier 5 year time charter with an oil major.